Cargando…
Role of Calcium-activated Potassium Channels in Atrial Fibrillation Pathophysiology and Therapy
Small-conductance Ca(2+)-activated potassium (SK) channels are relative newcomers within the field of cardiac electrophysiology. In recent years, an increased focus has been given to these channels because they might constitute a relatively atrial-selective target. This review will give a general in...
Autores principales: | Diness, Jonas G., Bentzen, Bo H., Sørensen, Ulrik S., Grunnet, Morten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Journal of Cardiovascular Pharmacology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4692285/ https://www.ncbi.nlm.nih.gov/pubmed/25830485 http://dx.doi.org/10.1097/FJC.0000000000000249 |
Ejemplares similares
-
The K(Ca)2 Channel Inhibitor AP30663 Selectively Increases Atrial Refractoriness, Converts Vernakalant-Resistant Atrial Fibrillation and Prevents Its Reinduction in Conscious Pigs
por: Diness, Jonas Goldin, et al.
Publicado: (2020) -
First Clinical Study with AP30663 ‐ a K(Ca)2 Channel Inhibitor in Development for Conversion of Atrial Fibrillation
por: Gal, Pim, et al.
Publicado: (2020) -
Small conductance calcium activated K(+) channel inhibitor decreases stretch induced vulnerability to atrial fibrillation
por: Yan, Yannan, et al.
Publicado: (2021) -
Termination of Vernakalant-Resistant Atrial Fibrillation by Inhibition of Small-Conductance Ca(2+)-Activated K(+) Channels in Pigs
por: Diness, Jonas Goldin, et al.
Publicado: (2017) -
Mechanisms of Action of the KCa2-Negative Modulator AP30663, a Novel Compound in Development for Treatment of Atrial Fibrillation in Man
por: Bentzen, Bo Hjorth, et al.
Publicado: (2020)